PAUL CAPITAL
Paul Capital was formed in 1991 as a pioneer in the secondary market, providing creative liquidity solutions to investors in private equity limited partnerships and portfolios of direct investments. In 1999, Paul Capital added its Healthcare Platform to invest in royalty and revenue interests in life science products. Today, Paul Capital sees the world from the vantage point of an experienced investor with unique insight and the ability to build compelling solutions for institutional investors. The team has grown to nearly 100 employees, with offices in Hong Kong, London, New York, Paris, San Francisco and São Paulo, managing a total of more than $6 billion across its distinct investment platforms.
PAUL CAPITAL
Social Links:
Industry:
Finance Life Science Venture Capital
Founded:
1991-01-01
Status:
Closed
Contact:
415-283-4300
Email Addresses:
[email protected]
Technology used in webpage:
SSL By Default Amazon GoDaddy SSL Amazon California Region Cogent Communications
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Bridges Israel
Bridges Israel is an impact investment fund.
Futureworks Capital Partners
Futureworks Capital Partners providing outsourced investment and liquidity solutions to institutional investors.
Current Advisors List
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2011-04-12 | Carbon Black | Paul Capital investment in Venture Round - Carbon Black | 12.5 M USD |
2011-02-22 | Recyclebank | Paul Capital investment in Series C - Recyclebank | 14 M USD |
2010-07-21 | Tethys BioScience | Paul Capital investment in Venture Round - Tethys BioScience | 23 M USD |
2010-01-05 | Phase III Development | Paul Capital investment in Private Equity Round - Phase III Development | 100 M USD |
2009-12-22 | UCB | Paul Capital investment in Post-IPO Equity - UCB | 100 M USD |
2008-08-21 | SpePharm | Paul Capital investment in Venture Round - SpePharm | 26 M EUR |
2007-06-26 | On-X Life Technologies | Paul Capital investment in Venture Round - On-X Life Technologies | 32 M USD |
2006-11-29 | Acorda Therapeutics | Paul Capital investment in Post-IPO Equity - Acorda Therapeutics | 10 M USD |
2005-06-09 | Verus Pharmaceuticals | Paul Capital investment in Series A - Verus Pharmaceuticals | 78 M USD |
2000-05-04 | ROXY.com | Paul Capital investment in Private Equity Round - ROXY.com | 25 M USD |